Mirae Asset Global Investments Co., Ltd. Bei Gene, Ltd. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $20 Billion
  • Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,173 shares of BGNE stock, worth $822,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,173
Holding current value
$822,957
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$129.52 - $174.32 $540,486 - $727,437
4,173 New
4,173 $595,000
Q1 2023

May 04, 2023
BUY
$215.53 - $274.5 $2.41 Million - $3.07 Million
11,166 New
11,166 $2.41 Million
Q3 2022

Nov 10, 2022
SELL
$131.8 - $202.24 $10.5 Million - $16.1 Million
-79,743 Reduced 86.78%
12,148 $1.64 Million
Q2 2022

Jul 26, 2022
SELL
$121.11 - $216.05 $817,250 - $1.46 Million
-6,748 Reduced 6.84%
91,891 $14.9 Million
Q1 2022

May 10, 2022
SELL
$146.52 - $269.56 $2.32 Million - $4.27 Million
-15,832 Reduced 13.83%
98,639 $18.6 Million
Q4 2021

Feb 08, 2022
SELL
$248.56 - $389.34 $5.42 Million - $8.49 Million
-21,803 Reduced 16.0%
114,471 $31 Million
Q3 2021

Nov 15, 2021
SELL
$249.6 - $403.14 $5.57 Million - $8.99 Million
-22,300 Reduced 14.06%
136,274 $49.5 Million
Q2 2021

Aug 11, 2021
SELL
$292.75 - $367.01 $409,850 - $513,814
-1,400 Reduced 0.88%
158,574 $54.4 Million
Q1 2021

May 13, 2021
BUY
$260.64 - $382.12 $13.9 Million - $20.5 Million
53,520 Added 50.28%
159,974 $55.7 Million
Q4 2020

Feb 10, 2021
BUY
$221.31 - $316.61 $2.11 Million - $3.02 Million
9,535 Added 9.84%
106,454 $27.5 Million
Q3 2020

Nov 12, 2020
BUY
$189.18 - $286.44 $9.85 Million - $14.9 Million
52,074 Added 116.12%
96,919 $27.8 Million
Q2 2020

Aug 11, 2020
BUY
$123.9 - $195.41 $125,510 - $197,950
1,013 Added 2.31%
44,845 $8.45 Million
Q1 2020

May 12, 2020
SELL
$121.84 - $173.19 $2.07 Million - $2.95 Million
-17,005 Reduced 27.95%
43,832 $5.4 Million
Q4 2019

Feb 12, 2020
BUY
$115.78 - $208.34 $165,681 - $298,134
1,431 Added 2.41%
60,837 $10.1 Million
Q3 2019

Nov 12, 2019
BUY
$120.61 - $148.29 $7.16 Million - $8.81 Million
59,406 New
59,406 $7.27 Million
Q2 2019

Aug 13, 2019
SELL
$113.99 - $146.86 $188,311 - $242,612
-1,652 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$122.82 - $151.83 $202,898 - $250,823
1,652 New
1,652 $218,000

Others Institutions Holding BGNE

# of Institutions
213
Shares Held
45.5M
Call Options Held
106K
Put Options Held
93.1K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $20.5B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email